University of Lyon
Professor Pierre Miossec MD PhD is professor of Clinical Immunology at the University of Lyon, France. He worked with Morris Ziff as a research fellow at the University of Texas in Dallas, where he started his research on the role of cytokines and T cells in the context of arthritis. He was the first to identify the destructive properties of interleukin-17 and to introduce the concept of its production by a new T cell subset. This has led to the targeting of IL-17 in a growing number of diseases.
He has received the EULAR Robecchi Prize for Rheumatology Research (1995), the most prestigious Carol Nachman prize in Rheumatology (2010) for his work on IL-17, the Morris Ziff lecture prize in Dallas (2010), the distinguished basic investigator award of the American College of Rheumatology (2015), the Gerald Weissmann prize, New York University (2016). He has been elected senior member of the Institut Universitaire de France (2011), membre correspondant de l’Académie Nationale de Médecine (2016), and to the prestigious Association of American Physicians in 2019.